Search research articles
Contact Us
Filters
Showing results (161-170 of 166) with videos related to
Page
of 17
Sort By:
You have reached the last page of results.
This site can display upto 166 results.
Journal of Cardiovascular Pharmacology
|
October 1, 1992
Hemodynamic and neurohumoral responses to intravenous nicorandil in congestive heart failure in humans
T D Giles, I L Pina, A C Quiroz, et al.
The American Journal of Cardiology
|
January 15, 1990
Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failure
M A Fifer, C R Molina, A C Quiroz, et al.
Circulation
|
February 23, 2000
Effect of mibefradil, a T-type calcium channel blocker, on morbidity and mortality in moderate to severe congestive heart failure: the MACH-1 study. Mortality Assessment in Congestive Heart Failure Trial
T B Levine, P J Bernink, A Caspi, et al.
Journal of Human Hypertension
|
August 31, 2007
Achieving blood pressure goals globally: five core actions for health-care professionals. A worldwide call to action
G Bakris, M Hill, G Mancia, et al.
The American Journal of Medicine
|
February 1, 1982
Multiclinic controlled trial of diltiazem for Prinzmetal's angina
J S Schroeder, R L Feldman, T D Giles, et al.
Congestive Heart Failure (Greenwich, Conn.)
|
February 6, 2002
Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examination
C V Leier, J B Young, T B Levine, et al.
Page
of 17
Search research articles
Search
Showing results (161-170 of 166) with videos related to
Sort By:
Page
of 17
You have reached the last page of results.
This site can display upto 166 results.
Journal of Cardiovascular Pharmacology
|
October 1, 1992
Hemodynamic and neurohumoral responses to intravenous nicorandil in congestive heart failure in humans
T D Giles, I L Pina, A C Quiroz, et al.
The American Journal of Cardiology
|
January 15, 1990
Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failure
M A Fifer, C R Molina, A C Quiroz, et al.
Circulation
|
February 23, 2000
Effect of mibefradil, a T-type calcium channel blocker, on morbidity and mortality in moderate to severe congestive heart failure: the MACH-1 study. Mortality Assessment in Congestive Heart Failure Trial
T B Levine, P J Bernink, A Caspi, et al.
Journal of Human Hypertension
|
August 31, 2007
Achieving blood pressure goals globally: five core actions for health-care professionals. A worldwide call to action
G Bakris, M Hill, G Mancia, et al.
The American Journal of Medicine
|
February 1, 1982
Multiclinic controlled trial of diltiazem for Prinzmetal's angina
J S Schroeder, R L Feldman, T D Giles, et al.
Congestive Heart Failure (Greenwich, Conn.)
|
February 6, 2002
Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examination
C V Leier, J B Young, T B Levine, et al.
Page
of 17